Market Vectors Pharmaceutical ETF (PPH)
Description
The investment seeks to track the performance of the MVIS U.S. Listed Pharmaceutical 25 Index. The PPH ETF contains 25 constituents. It is focused on blend holdings in the North America region.
Price $68.21 as of 2022-10-20Cost/Risk/Yield
| Dividend yield | 1.81% |
| Expense ratio | 0.35% |
| Average spread | 0.044% |
| 1Y roundtrip cost | 0.394% |
Historic prices
Total Returns (including dividends)
Monthly returns heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | -1.4% | -0.2% | 5.3% | -2.2% | 2.2% | -3.0% | 0.4% | -8.0% | -4.9% | 1.9% | -10.1% | ||
| 2021 | 2.5% | -0.9% | 2.2% | 1.2% | 3.8% | 1.3% | 2.9% | 1.6% | -4.2% | 3.7% | -5.0% | 8.1% | 17.2% |
| 2020 | -0.1% | -7.9% | -7.9% | 12.0% | 4.5% | -1.6% | 1.6% | 2.4% | -3.7% | -4.9% | 10.4% | 2.6% | 7.6% |
| 2019 | 7.0% | 3.6% | 0.0% | -3.5% | -6.0% | 7.2% | -1.6% | -1.8% | 1.0% | 4.6% | 4.8% | 3.6% | 18.8% |
| 2018 | 3.7% | -6.0% | -1.7% | 0.5% | 2.4% | 1.6% | 5.4% | 2.8% | 1.1% | -5.7% | 3.7% | -12.3% | -4.5% |
| 2017 | -0.4% | 6.3% | -0.8% | 1.0% | 3.9% | 3.0% | -1.3% | -4.1% | 3.8% | -4.0% | 4.0% | 3.5% | 14.9% |
| 2016 | -7.8% | -4.7% | 0.2% | 2.4% | 1.1% | -0.4% | 6.1% | -4.8% | -2.4% | -9.5% | 0.1% | 1.6% | -18.3% |
| 2015 | 1.7% | 5.9% | 1.5% | 1.4% | 3.1% | -3.0% | 5.3% | -8.3% | -7.4% | 3.5% | -0.2% | 1.2% | 4.6% |
| 2014 | 1.9% | 10.0% | -1.9% | 3.7% | 0.2% | 3.1% | -1.9% | 2.6% | 2.2% | 0.0% | 4.5% | -2.6% | 21.7% |
| 2013 | 7.1% | 0.4% | 5.5% | 3.7% | 0.1% | -1.9% | 5.7% | -2.7% | 2.9% | 4.4% | 4.8% | 2.3% | 32.2% |
| 2012 | 0.2% | 2.5% | 3.0% | 1.0% | -5.2% | 5.3% | 1.9% | 0.4% | 3.4% | -0.5% | 0.0% | 0.7% | 12.6% |
| 2011 | -1.3% | 2.9% | 0.2% | 7.0% | 2.1% | -1.9% | -2.4% | -1.7% | -4.0% | 4.4% | 2.4% | 4.2% | 12.0% |
| 13.0% | 12.0% | 5.5% | 28.2% | 12.1% | 9.6% | 21.9% | -21.7% | -12.2% | -2.1% | 29.5% | 12.9% |
Historical Dividends
Monthly dividend heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 0.44 | 0.25 | 0.27 | 0.96 | |||||||||
| 2021 | 0.35 | 0.29 | 0.34 | 0.27 | 1.25 | ||||||||
| 2020 | 0.34 | 0.25 | 0.25 | 0.27 | 1.10 | ||||||||
| 2019 | 0.39 | 0.28 | 0.29 | 0.17 | 1.14 | ||||||||
| 2018 | 0.39 | 0.25 | 0.23 | 0.20 | 1.08 | ||||||||
| 2017 | 0.47 | 0.30 | 0.22 | 0.15 | 1.14 | ||||||||
| 2016 | 0.63 | 0.29 | 0.21 | 0.14 | 1.27 | ||||||||
| 2015 | 0.50 | 0.28 | 0.28 | 0.20 | 1.26 | ||||||||
| 2014 | 0.40 | 0.26 | 0.20 | 0.24 | 1.10 | ||||||||
| 2013 | 0.39 | 0.27 | 0.20 | 0.17 | 1.04 | ||||||||
| 2012 | 1.35 | 1.35 | |||||||||||
| 0.00 | 0.00 | 0.00 | 4.29 | 0.00 | 0.00 | 2.71 | 0.00 | 0.00 | 2.52 | 0.00 | 3.18 |
Sectors and Top Holdings
| Security | % Assets |
|---|---|
| Merck & Co., Inc. | 5.84% |
| Astrazeneca PLC Sponsored ADR | 5.54% |
| Novo Nordisk A/S Sponsored ADR Class B | 5.44% |
| Sanofi SA Sponsored ADR | 5.09% |
| AbbVie, Inc. | 5.06% |
| Eli Lilly and Company | 5.06% |
| Novartis AG Sponsored ADR | 4.84% |
| Johnson & Johnson | 4.82% |
| GlaxoSmithKline plc Sponsored ADR | 4.76% |
| Pfizer Inc. | 4.72% |
| Zoetis, Inc. Class A | 4.65% |
| McKesson Corporation | 4.55% |
| Bristol-Myers Squibb Company | 4.48% |
| AmerisourceBergen Corporation | 4.45% |
| Catalent Inc | 4.36% |
| Top 15 Weights | 73.66% |
Compare with similar ETFs
| PPH | FFEB | IHE | PJP | SIXA | UMAR | |
|---|---|---|---|---|---|---|
| Product name | Market Vectors Pharmaceutical ETF | FT Cboe Vest U.S. Equity Buffer ETF - February | iShares U.S. Pharmaceuticals ETF | PowerShares Dynamic Pharmaceuticals Portfolio ETF | 6 Meridian Mega Cap Equity ETF | Innovator S&P 500 Ultra Buffer ETF March Series |
| Issuer | VanEck | FT Cboe Vest | iShares | Invesco | Meridian | Innovator |
| Price | $68.21 | $34.421 | $170.275 | $72.19 | $30.952 | $27.908 |
| Expense Ratio | 0.35% |  0.85% | 0.42% | 0.58% | 0.86% | 0.79% |
| Average Spread | 0.044% | 0.261% | 0.070% | 0.097% | 0.162% | 0.358% |
| AUM | $296,076,000 | $239,226,000 | $338,229,000 | $393,648,000 | $159,032,000 | $31,375,300 |
| Shares | 4,340,652 | 6,950,000 | 1,986,374 | 5,452,937 | 5,138,028 | 1,124,240 |
| Average Daily Volume | 171,153 | 65,797 | 10,990 | 12,790 | 5,380 | 35,453 |
| Home page | Visit external site | Visit external site | Visit external site | Visit external site | Visit external site | Visit external site |
| Inception Date | 2000-02-01 | 2020-02-21 | 2006-05-01 | 2005-06-23 | 2020-05-11 | 2020-03-02 |
| Index Tracked | MVIS U.S. Listed Pharmaceutical 25 Index | No Underlying Index | DJ US Select / Pharmaceutical | Dynamic Pharmaceutical Intellidex Index | No Underlying Index | No Underlying Index |
| Category | Health & Biotech Equities | n/a | Health & Biotech Equities | Health & Biotech Equities | Large Cap Blend Equities | Large Cap Blend Equities |
| Asset Class | Equity | Equity | Equity | Equity | Equity | Equity |
| Asset Class Size | Large/Mid Caps | Large/Mid Caps | Large/Mid/Small Caps | Large Caps | ||
| Value or Growth | Blend | Blend | Growth | Blend | Blend | Blend |
| Region | North America | North America | North America | North America | North America | North America |
| Countries | Broad | U.S. | U.S. | U.S. | U.S. | U.S. |
| Annual Dividend Rate | $1.232 | $0 | $3.186 | $0.763 | $0.712 | $0 |
| Annual Dividend Yield | 0.018% | 0.000% | 0.019% | 0.011% | 0.023% | 0.000% |
| Number of Holdings | 25 | 0 | 47 | 22 | 48 | 0 |
| YTD Return | -10.22% | -10.50% | -13.59% | -10.32% | -13.46% | -6.33% |
| Beta | 0.80 | 0.66 | 0.83 | 0.84 | 0.76 | 0.33 |
| Upside Beta | 0.12 | 0.51 | 0.00 | 0.04 | 0.45 | 0.27 |
| Downside Beta | 0.24 | 0.13 | 0.09 | 0.18 | -0.03 | 0.06 |
| Volatility 1Y | 16.98% | 14.86% | 17.50% | 19.05% | 16.86% | 7.73% |
| Sharpe Ratio 3Y | 0.57 | 0.00 | 0.59 | 0.62 | 0.00 | 0.00 |
| Treynor Ratio 3Y | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 |